Keith Lamont Cummings is CFO at PLIANT THERAPEUTICS, INC. (PLRX). They have made 3 open-market trades across 1 company since 2020, most recently 2026-01-20.
CIK 0001809204
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PLRX | 297,214 | $268K |
Shares reported on the most recent Form 4, priced at the 2026-01-22 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PLRX | SELL · 10b5-1 | 2026-01-20 | 2026-01-22 | $1.28 | $31K | -5.5% | -3.9% | +0.8% |
| PLRX | SELL · 10b5-1 | 2025-01-17 | 2025-01-22 | $11.20 | $451K | +4.1% | -71.3% | -86.0% |
| PLRX | SELL · 10b5-1 | 2024-07-10 | 2024-07-12 | $11.56 | $252K | -2.5% | -8.9% | -10.8% |
| PLRX | SELL · 10b5-1 | 2024-01-17 | 2024-01-19 | $17.23 | $337K | +7.4% | -6.8% | -26.9% |
| PLRX | SELL · 10b5-1 | 2023-07-17 | 2023-07-19 | $18.01 | $712K | +0.2% | -5.8% | -17.0% |
| PLRX | SELL · 10b5-1 | 2023-03-30 | 2023-04-03 | $26.52 | $528K | +0.2% | -9.7% | -31.9% |
| PLRX | SELL | 2023-01-23 | 2023-01-25 | $35.00 | $1.1M | -6.8% | -11.3% | -13.4% |
| PLRX | SELL | 2022-12-20 | 2022-12-21 | $19.10 | $368K | -1.3% | +18.3% | +44.6% |
| PLRX | SELL | 2020-12-01 | 2020-12-02 | $30.04 | $1.1M | -3.5% | -13.7% | +29.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.